vs
ABM INDUSTRIES INC（ABM）与Encompass Health Corp（EHC）财务数据对比。点击上方公司名可切换其他公司
ABM INDUSTRIES INC的季度营收约是Encompass Health Corp的1.5倍（$2.3B vs $1.5B），Encompass Health Corp净利率更高（9.5% vs 1.5%，领先7.9%），Encompass Health Corp同比增速更快（9.9% vs 5.4%），Encompass Health Corp自由现金流更多（$116.7M vs $112.7M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs 5.3%）
ABM工业是美国知名的设施管理服务商，1909年由莫里斯·罗森伯格在加利福尼亚州旧金山创立。其业务覆盖电气、照明、能源管理、设施工程、电气化、暖通空调、机电运维、保洁、景观养护、停车场管理、交通配套等多元设施服务领域，为各类客户提供一体化的场地运营解决方案。
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
ABM vs EHC — 直观对比
营收规模更大
ABM
是对方的1.5倍
$1.5B
营收增速更快
EHC
高出4.5%
5.4%
净利率更高
EHC
高出7.9%
1.5%
自由现金流更多
EHC
多$4.0M
$112.7M
两年增速更快
EHC
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.3B | $1.5B |
| 净利润 | $34.8M | $146.1M |
| 毛利率 | 11.8% | — |
| 营业利润率 | 3.0% | 16.7% |
| 净利率 | 1.5% | 9.5% |
| 营收同比 | 5.4% | 9.9% |
| 净利润同比 | 394.9% | 20.8% |
| 每股收益（稀释后） | $0.56 | $1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABMEHC
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $2.2B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.0B | $1.3B | ||
| Q1 24 | $2.1B | $1.3B |
净利润ABMEHC
| Q4 25 | $34.8M | $146.1M | ||
| Q3 25 | $41.8M | $126.5M | ||
| Q2 25 | $42.2M | $142.1M | ||
| Q1 25 | $43.6M | $151.5M | ||
| Q4 24 | $-11.8M | $120.9M | ||
| Q3 24 | $4.7M | $108.2M | ||
| Q2 24 | $43.8M | $114.1M | ||
| Q1 24 | $44.7M | $112.5M |
毛利率ABMEHC
| Q4 25 | 11.8% | — | ||
| Q3 25 | 12.3% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 12.5% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 11.8% | — |
营业利润率ABMEHC
| Q4 25 | 3.0% | 16.7% | ||
| Q3 25 | 3.8% | 14.9% | ||
| Q2 25 | 3.9% | 16.2% | ||
| Q1 25 | 3.7% | 16.4% | ||
| Q4 24 | 0.9% | 14.3% | ||
| Q3 24 | 1.8% | 13.6% | ||
| Q2 24 | 4.0% | 14.3% | ||
| Q1 24 | 3.6% | 13.6% |
净利率ABMEHC
| Q4 25 | 1.5% | 9.5% | ||
| Q3 25 | 1.9% | 8.6% | ||
| Q2 25 | 2.0% | 9.7% | ||
| Q1 25 | 2.1% | 10.4% | ||
| Q4 24 | -0.5% | 8.6% | ||
| Q3 24 | 0.2% | 8.0% | ||
| Q2 24 | 2.2% | 8.8% | ||
| Q1 24 | 2.2% | 8.5% |
每股收益（稀释后）ABMEHC
| Q4 25 | $0.56 | $1.43 | ||
| Q3 25 | $0.67 | $1.24 | ||
| Q2 25 | $0.67 | $1.39 | ||
| Q1 25 | $0.69 | $1.48 | ||
| Q4 24 | $-0.18 | $1.18 | ||
| Q3 24 | $0.07 | $1.06 | ||
| Q2 24 | $0.69 | $1.12 | ||
| Q1 24 | $0.70 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $104.1M | $72.2M |
| 总债务越低越好 | — | $2.4B |
| 股东权益账面价值 | $1.8B | $2.4B |
| 总资产 | $5.3B | $7.1B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资ABMEHC
| Q4 25 | $104.1M | $72.2M | ||
| Q3 25 | $69.3M | $48.7M | ||
| Q2 25 | $58.7M | $99.1M | ||
| Q1 25 | $59.0M | $95.8M | ||
| Q4 24 | $64.6M | $85.4M | ||
| Q3 24 | $86.3M | $147.8M | ||
| Q2 24 | $60.7M | $154.4M | ||
| Q1 24 | $58.0M | $134.4M |
总债务ABMEHC
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
股东权益ABMEHC
| Q4 25 | $1.8B | $2.4B | ||
| Q3 25 | $1.8B | $2.4B | ||
| Q2 25 | $1.8B | $2.3B | ||
| Q1 25 | $1.8B | $2.2B | ||
| Q4 24 | $1.8B | $2.1B | ||
| Q3 24 | $1.8B | $2.0B | ||
| Q2 24 | $1.8B | $1.8B | ||
| Q1 24 | $1.8B | $1.7B |
总资产ABMEHC
| Q4 25 | $5.3B | $7.1B | ||
| Q3 25 | $5.3B | $6.9B | ||
| Q2 25 | $5.3B | $6.8B | ||
| Q1 25 | $5.2B | $6.6B | ||
| Q4 24 | $5.1B | $6.5B | ||
| Q3 24 | $5.0B | $6.5B | ||
| Q2 24 | $4.9B | $6.4B | ||
| Q1 24 | $5.0B | $6.2B |
负债/权益比ABMEHC
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $133.4M | $346.0M |
| 自由现金流经营现金流 - 资本支出 | $112.7M | $116.7M |
| 自由现金流率自由现金流/营收 | 4.9% | 7.6% |
| 资本支出强度资本支出/营收 | 0.9% | 14.8% |
| 现金转化率经营现金流/净利润 | 3.83× | 2.37× |
| 过去12个月自由现金流最近4个季度 | $155.1M | $439.2M |
8季度趋势，按日历期对齐
经营现金流ABMEHC
| Q4 25 | $133.4M | $346.0M | ||
| Q3 25 | $174.9M | $270.8M | ||
| Q2 25 | $32.3M | $270.2M | ||
| Q1 25 | $-106.2M | $288.6M | ||
| Q4 24 | $30.4M | $278.8M | ||
| Q3 24 | $79.4M | $267.8M | ||
| Q2 24 | $117.0M | $217.4M | ||
| Q1 24 | $-100.0K | $238.8M |
自由现金流ABMEHC
| Q4 25 | $112.7M | $116.7M | ||
| Q3 25 | $150.1M | $83.7M | ||
| Q2 25 | $15.2M | $113.3M | ||
| Q1 25 | $-122.9M | $125.5M | ||
| Q4 24 | $15.6M | $80.1M | ||
| Q3 24 | $63.9M | $120.3M | ||
| Q2 24 | $101.5M | $60.5M | ||
| Q1 24 | $-13.7M | $99.4M |
自由现金流率ABMEHC
| Q4 25 | 4.9% | 7.6% | ||
| Q3 25 | 6.7% | 5.7% | ||
| Q2 25 | 0.7% | 7.8% | ||
| Q1 25 | -5.8% | 8.6% | ||
| Q4 24 | 0.7% | 5.7% | ||
| Q3 24 | 3.1% | 8.9% | ||
| Q2 24 | 5.0% | 4.6% | ||
| Q1 24 | -0.7% | 7.6% |
资本支出强度ABMEHC
| Q4 25 | 0.9% | 14.8% | ||
| Q3 25 | 1.1% | 12.7% | ||
| Q2 25 | 0.8% | 10.8% | ||
| Q1 25 | 0.8% | 11.2% | ||
| Q4 24 | 0.7% | 14.1% | ||
| Q3 24 | 0.7% | 10.9% | ||
| Q2 24 | 0.8% | 12.1% | ||
| Q1 24 | 0.7% | 10.6% |
现金转化率ABMEHC
| Q4 25 | 3.83× | 2.37× | ||
| Q3 25 | 4.18× | 2.14× | ||
| Q2 25 | 0.77× | 1.90× | ||
| Q1 25 | -2.44× | 1.90× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | 16.89× | 2.48× | ||
| Q2 24 | 2.67× | 1.91× | ||
| Q1 24 | -0.00× | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABM
| Facility Service Line Janitorial | $729.5M | 32% |
| Technical Solutions | $298.6M | 13% |
| Aviation | $296.7M | 13% |
| Education | $233.8M | 10% |
| Engineering And Infrastructure Service Line | $211.3M | 9% |
| Engineering And Infrastructure Service Line Operations And Maintenance | $207.2M | 9% |
| Facility Service Line Aviation Services | $134.4M | 6% |
| Facility Service Line Parking And Transportation | $108.0M | 5% |
| Management Reimbursement Revenue | $86.9M | 4% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
